The role of peri-operative transoesophageal echocardiography cardiovascular surgery. (5, 6, 7, 8, 9, 10) More recent retrospective analyses of prospectively collected data suggest that around 5.6% of surgical procedures are altered on the basis of intra-operative echocardiographic findings and that there are cost-benefit savings particularly during combined valve and graft operations. (11, 12, 13) Recently, the roles for peri-operative echocardiography have also extended to include intensive care (14, 15) and non-cardiac surgery. (16, 17, 18) Although it is complex to scientifically prove the benefits of a diagnostic monitor, TOE has been shown to strongly influence intra-operative anaesthetic decisions, particularly in patients with increased risk factors for haemodynamic instability or myocardial ischaemia. In a prospective observational case series of 98 patients undergoing abdominal surgery, the judgement of the anaesthetists was that TOE led to useful alterations in intraoperative care such as administration of fluids, vasoactive drugs and β blockers. In some patients, use of the pulmonary artery catheter was obviated. (19) Similarly, in another case series comprising 90 patients undergoing vascular, visceral and chest surgery, TOE directed changes in drug (47%) and fluid therapy (24%). 
PERI-OPERATIVE TOE

IntroductIon
In 1976 transoesophageal echocardiography (TOE) was introduced into clinical practice. (1) Within a decade, its use extended from cardiology departments into the cardiac surgical arena. However,
at that time few probes were available for the operating theatre.
Indeed in a report from the United States in 1988, only about 50 TOE probes were accessible for intra-operative use. (2) Furthermore, despite its utility for cardiac surgery, it became evident that few cardiologists were able to spend long periods in the operating theatre. Over time much enthusiasm and expertise for TOE has developed amongst cardiac anaesthesiologists, and by 2001, 94%
of respondents in a survey of the Society of Cardiovascular
Anaesthesiologists utilised intra-operative echocardiography in their routine practice.
Over the past 30 years technology has improved tremendously and intra-operative TOE has become an established imaging modality and the gold standard intra-operative cardiac monitor and diagnostic tool in certain cardiac procedures, e.g. mitral valve repair, congenital heart surgery, etc. (4) There is evidence that intra-operative TOE from the dataset. (23) It reduces significantly the number of steps required to complete a comprehensive examination, thus minimising examination time. (24) However, detailed quantification i.e. off line intra-operative geometric analysis using integrated 3-D mitral valve and left ventricular quantification software is slightly cumbersome. (25) Early evidence suggests that real-time 3-D TOE adds additional information to the intra-operative comprehensive examination and decision making process during cardiac surgery. (26) In addition, 3-D images facilitate communication between the echocardiographer and other members of the surgical team. (27) It is expected that a combined 2-D and 3-D TOE examination will, in the foreseeable future, become routine for intra-operative surgical guidance. (28) 
Category I indications
Life-threatening, persistent haemodynamic instability in the acute setting is an important indication for TOE. The use of a pulmonary artery (PA) catheter in combination with the thermodilution technique has been common in such situations. (35) However, there is no conclusive evidence to date that using a PA catheter improves outcome in critically ill patients. (36) During haemodynamic evaluation TOE has proved reliable and comparative with the PA catheter and standard thermodilution techniques. (37) It can provide a real time and quick analysis of cardiovascular dysfunction and its use prior to other forms of invasive monitoring has been suggested. (38) A survey has shown that among anaesthesiologists with echocardiography training in the USA and Canada, TOE was preferred as monitor to the PA catheter in critically ill patients and complex cardiovascular surgery. (39) TOE examination may provide information quicker and less invasive than the PA catheter and can avoid uncertainty when the cause of instability is unclear or resistant to treatment. It will also provide more extensive real time information with regards to heart function and structure. However, when data from both a PA catheter and TOE are available, they should be viewed as complementary. 
PERI-OPERATIVE TOE
FIgurE 1a: A real-time transgastric short axis view of the left ventricle allows accurate qualitative evaluation of ventricular filling and function and is of great value in acute situations. This image demonstrates a non-compliant left ventricle with severe concentric hypertrophy and preserved systolic function. Should this patient become unstable, volume loading and a higher filling pressure will be the management of choice.
FIgurE 1b: A real-time transgastric short axis view of a failing and dilated left ventricle: Should this patient become unstable, inotropic support will be required. Mitral valve repair and replacement are now performed earlier in disease staging than before. (44) The role of intra-operative TOE for these conditions is well established, (33, 45) and has significant impact upon post-operative outcome. (46, 47) Owing to the close relationship of the mitral valve to the oesophagus, clear images can be obtained. By using different views and scanning modalities including 3-D TOE, specific leaflet morphology can be identified and pathology quantified (48) (Figure 2a, Figure 2b , Figure 2c ). Ventricular dysfunction that has prognostic value may be confirmed by TOE. At the end of surgery, TOE is used to provide quality assurance by checking for residual mitral regurgitation and paraprosthetic leak. Although routine valve replacement is considered a category II indication, TOE provides information that can guide modifications of anaesthetic and surgical care which lead to improved outcome. (57) Use of TOE during more complex valve replacement like stentless aortic valve or homograft is invaluable and classed as category I. (33) These prostheses require surgical experience and accurate intra-operative TOE analysis such as precise diameter measurements of the aortic root and ascending aorta as well as the origin of the coronary ostia. (58, 59) Discrepancy between measurements due to dilatation of the ascending aorta may lead to tethering and splaying of the stentless prosthetic leaflets after implantation, which may result in AR. Considering these variations in PERI-OPERATIVE TOE FIgurE 3b: During repair the surgeon commented on the extreme calcification of the annulus. After repair with complete ring prosthesis a high velocity paraprosthesis regurgitant jet was observed. The arrow points at a residual cleft between P1 and P2 on the anterolateral side outside the annuloplasty ring.
FIgurE 4:
Accurate measurements of the aortic root are necessary to guide surgical repair of the aortic valve. In this patient the left ventricular outflow tract diameter measures large at 3.2cm, while the sinotubular junction is dilated at 6.1cm diameter. This means that the surgeon needs to address both the ascending aorta and annulus.
cations. TOE is more sensitive than trans-thoracic echo (TTE) for detection of thoracic aortic dissection and has similar sensitivity and specificity to CT and MRI imaging. (61) Rapid intra-operative assessment of the aorta is necessary to successfully guide the surgeon. The ascending and descending aorta should be visualised to demonstrate the true lumen, false lumen, intimal flap and entry site. TOE can image the ascending aorta but is limited due to the anatomical location of the trachea and left main stem bronchus, which lies between the oesophagus and aortic arch. As only 80% of the ascending aorta may be clearly visualised, it is often difficult to examine the proximal arch (62) and epi-aortic scanning may be indicated. 
Intra-operative TOE is essential for congenital heart surgery i.e. a category I indication. (33, 66, 67, 68) Prior to surgery TOE may display clearer images than those of transthoracic echocardiography in patients with pulmonary disease or chest deformities. Cardiac structural abnormalities can be demonstrated and functional haemodynamic limitations can be measured. (69) Whether it is an anaesthetist or cardiologist, it is important that the physician performing intra-operative paediatric TOE examinations is experienced and has a proper understanding of congenital cardiac pathology and the intra-operative conditions. (70) A complete sequential segmental TOE analysis is recommended, similar to the full pre-operative transthoracic assessment in any patient with congenital heart disease. (71) Moreover, in patients with intra-or extracardiac shunt it may be useful to calculate shunt ratio between the pulmonary and systemic circulations. (72) After cardiopulmonary bypass, TOE has been shown to provide initial quality assurance of the surgery. (73) Recently, there have been advances in 3-D TOE for adolescents, (74) as well as multiplane technology which can now be applied in children as small as 2kg. (31) A realistic problem with TOE in small children is possible probe compression of the airway and big vessels, leading to desaturation (75) and haemodynamic compromise. (76) Hypertrophic cardiomyopathy (HCM) can be diagnosed with TOE and also falls in the category I of indications. (77) Abnormal motion of the anterior leaflet of the mitral valve onto a hypertrophic interventricular septum during late systole leads to a high pressure gradient across the left ventricular outflow tract as well as dynamic TOE is an essential tool during surgical intervention for endocarditis. (33) It reveals pathology such as vegetations, abscesses and degree of extension to perivalvular tissue. Although more invasive than transthoracic echocardiography, TOE provides better views and has a higher sensitivity for detecting paravalvular abscesses, and vegetations (87-100%) on native and prosthetic valves. (79) Although the diagnosis of pericardial effusions and use of TOE during pericardial surgery falls in category 2, the task force has classed it as category 1 in patients with posterior or loculated effusions, when TOE is used to evaluate the adequacy of a pericardial window procedure. (32, 33) In spite of limited scientific evidence, it is expert opinion that TOE is beneficial during these procedures if it helps to avoid serious haemodynamic complications. 
Complications and contra-indications
Complication rates and mortality associated with the use of TOE are extremely low. Data for complications attributable to PERI-OPERATIVE TOE TOE are derived from cardiac anaesthetic practice. In a case series of 4 784 patients, six complications were detected, giving an incidence of 0.13%. (82) This rate is similar to that of another case series examining 7200 patients where TOE-associated morbidity and mortality was 0.2% and 0% respectively. (83) Typical injuries include a sore throat, dental injury, upper gastrointestinal haemorrhage and oesophageal perforation. Equipment familiarity and an experienced anaesthetic team avoid perhaps one of the most important potential complications -the anaesthetist's attention being distracted from patient care. The benefits of peri-operative echocardiography should therefore be weighed against the risks that it poses. (84) There are few absolute contra-indications. Recent oesophageal surgery, oesophageal strictures, diverticulae and tumours will be contra-indications. However, TOE may be used for patients with oral, oesophageal or gastric disease, if the expected benefit outweighs the potential risk, and provided appropriate precautions are taken (e.g. smallest possible probe). (34) Anti-coagulation with warfarin or heparin within the therapeutic range can only be considered a very relative contra-indication.
trAInIng And quAlIty AssurAncE
A substantial level of training is required to obtain maximum benefit from TOE as a high quality peri-operative monitor and diagnostic tool. The development of training and certification in echocardiography has been a long and intensive process in Europe and the USA. Excellent comprehensive TOE courses have been developed, (85) and working groups on TOE have published extensive practice and training guidelines on both sides of the Atlantic and in Japan. (86, 87) The American Society of Cardiothoracic Anaesthesiologists (SCA) developed the first formal examination in peri-operative TOE in 1998. (88) The SCA and American Society of Echocardiography (ASE) then combined forces to establish the National Board of Echocardiography, which had the responsibility to further administer examinations and develop a certification process in clinical echocardiography. The development of many cardiac surgical procedures and the reduction in peri-operative morbidity and mortality can be directly related to the use of TOE.
Furthermore, as our expectations for improved peri-operative outcomes continue to rise, we envisage that we will, in future, see an increase in the application of TOE for major non-cardiac surgery as well as for intensive care. With improvements in training, software, miniaturisation of technology and availability of affordable basic echocardiographic equipment, it is likely that this aspiration will be fulfilled.
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